fda removes tirzepatide from shortage list Lilly's weight-loss drug removed FDA's π¨ Alert: Tirzepatide No Longer
Description
Discover the benefits of semaglutide injections for weight loss at Thrive Aesthetic & Wellness
This medication is used to treat type 2 diabetes in adults by helping to control blood sugar levels
Concerned about costs

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Online eligibility review, weekly treatment and discreet home delivery statewide.

Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population
